Generics Industry Takes Action To Maintain Access In Ukraine
Medicines For Europe Calls On EU To Lead Coordination Of Supplies Via HERA
Efforts are being made across the European off-patent community to bolster the supply chain and ensure access to medicines in Ukraine, industry association Medicines for Europe tells Generics Bulletin. It has urged the EU to take a leading role in coordinating supplies through the HERA emergency response body.
You may also be interested in...
Fresh from being named as the new president of Medicines for Europe, Medichem CEO Elisabeth Stampa sets out the association’s priorities around investment in European manufacturing, as well as identifying key obstacles that must be overcome to create a sustainable environment for off-patent medicines, in an exclusive interview with Generics Bulletin.
Medicines for Europe has called for the EU’s IPCEI on health to encourage access to manufacturing incentives for APIs and off-patent medicines, which so far have been left out of the initiative.
Medichem CEO Elisabeth Stampa has been named as the new president of Medicines for Europe, setting out policy priorities that include bolstering the European API sector and supporting a “green transformation” for manufacturing.